David Avitabile has extensive experience in strategic communications, including senior-level roles at multinational communications companies in Europe and the United States. In addition to his role at Baird’s CMC, David is also the founder of MANA LLC. MANA is a strategic communications company that helps global organisations engage with their customers and communities of interest in powerful ways.
As President and partner at JFK Communications for ten years, David was responsible for agency growth, team development and management of key clients. Before helping to establish JFK Communications, David was Senior Vice President of Global Strategic Development for AXIS Healthcare Communications, a holding company consisting of eight diversified healthcare communications companies providing lifecycle management services to the global pharmaceutical and biotechnology industry. David was responsible for developing key client relationships for AXIS companies worldwide, and working with the presidents of each AXIS company to identify and pursue new business.
Prior to his role at AXIS, David helped to establish the London office of ApotheCom, a global medical communications company and the largest member of the AXIS family of companies. As Managing Director of ApotheCom Europe, David was responsible for business development, building the team at ApotheCom Europe, and ultimately hiring his replacement before returning to the United States to take on his new role at AXIS.
David has also held positions as Director of Business Development and Client Services Director at OCC Europe, headquarters of a global medical communications company with offices in Europe, the United States, Japan and Australia. At OCC, David was responsible for global business development, and overseeing a client services team managing global medical communications programs for clients including Johnson Johnson, AstraZeneca, Pharmacia and Shire Pharmaceuticals.
David’s public relations experience includes leadership roles working in the US and Europe. At interSCIENCE, a global healthcare communications agency with offices in London, New York and Washington, David was responsible for building and managing a highly successful client services team in the London office, and developing and implementing international programs for clients including Sanofi, Merck (MSD) and AstraZeneca. David has deep therapeutic area experience including work in oncology, cardiovascular, immunology, GI and CNS. He has launched a number of new compounds and has contributed to global product communications and commercialization teams for clients in the United States and Europe.